Gujarat Fluorochemicals Ltd.
Chemicals · NSE
52-week range
₹2,917 – ₹4,047
From 52w high
-6.9%
RSI (14)
71.9
vs SMA 50 / 200
↑ 50 · ↑ 200
Gujarat Fluorochemicals (FLUOROCHEM) is a Chemicals-sector stock trading at ₹3,769, a trailing PE of 63.1x against a sector peer range of 29x–100x. Five-year earnings have declined at a -19% CAGR and the debt-to-equity ratio stands at an elevated 22.5, while the stock has rallied 12.3% over the past 3 months to sit above both its 50-DMA and 200-DMA with an RSI of 71.9.
- ✓Forward PE of 44.0x represents a material compression from the trailing PE of 63.1x, indicating that consensus estimates embed a significant earnings recovery relative to today's price.
- ✓Current price of ₹3,769 is above both the 50-DMA (₹3,342) and 200-DMA (₹3,474), reflecting short-term and medium-term price recovery from what was a -6.9% drawdown from the 52-week high.
- ✓Trailing PE of 63.1x is below Solar Industries (100.1x) and roughly in line with Pidilite Industries (61.2x), placing FLUOROCHEM in the mid-range of its tracked peer set on this metric.
- ✓Profit margin of 13.5% indicates the business retains a positive earnings layer despite multi-year revenue and earnings contraction.
- ✗Five-year earnings CAGR of -19% and revenue CAGR of -1% signal persistent deterioration in core financial performance across the measurement window.
- ✗Debt-to-equity of 22.5 with a rising debt trend and FCF positivity in only 2 of the available historical years points to a capital structure that is heavily reliant on external financing during a period of shrinking earnings.
- ✗Quality score of 16 ranks FLUOROCHEM 5th out of 6 tracked Chemicals peers; consistency score of 17 and ROE above 15% in only 2 historical years reflect weak fundamental durability.
- ✗RSI of 71.9 after a 12.3% 3-month rally indicates the stock is in overbought territory even as the 1-year return remains negative at -2.75%, a combination that historically has preceded periods of consolidation or mean reversion in price.
- ·No news headlines were captured by the classifier for this stock; recent corporate actions, regulatory developments, or earnings announcements cannot be assessed from available data.
- ·The 3-month price gain of 12.3% has pushed the stock above both key moving averages (50-DMA and 200-DMA) for the first time in the recent period, a technical shift that follows what was a -2.75% trailing 1-year return.
- ·With 14 analysts tracked but no aggregated rating score available, the degree of sell-side conviction behind the implied earnings recovery embedded in the 44.0x forward PE cannot be verified from this dataset.
- ?Does the forward PE compression from 63.1x to 44.0x rest on a realistic earnings recovery pathway given that both revenue and earnings have contracted on a 5-year basis, or does it reflect optimism that is not yet supported by operational trends?
- ?How sustainable is the current debt-to-equity ratio of 22.5 if FCF generation remains intermittent and earnings continue to decline — what levers does the company have to reduce leverage?
- ?What explains the divergence between the 3-month price rally of 12.3% and the multi-year fundamental erosion, and is there a specific catalyst (e.g., fluorochemicals pricing cycle, capacity expansion, export orders) that the market is pricing in?
- ?Given that quality score (16) and consistency score (17) both rank near the bottom of the peer group, does FLUOROCHEM's premium valuation relative to lower-PE peers like Coromandel (29x) and PI Industries (32x) reflect a differentiated business model or a sector rotation trade?
PE
63.1
Forward PE
44.0
ROE
—
Profit margin
+13.5%
D/E
22.48
Dividend yield
+0.1%
Quality score
16/100
ROE 5y above 15%
2/5 yrs
FCF 5y positive
2/5 yrs
For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.Analysis generated 11 May 2026.